Information about medicinal products published on this website is provided for informational purposes only and does not constitute advertising, a public offer, an offer for sale, or instructions for use.
The use of medicinal products is permitted only upon a doctor’s prescription. Consultations are provided by clinic specialists in person or online in accordance with applicable law.
The use of medicinal products is permitted only upon a doctor’s prescription. Consultations are provided by clinic specialists in person or online in accordance with applicable law.
EVRA 60 mg/600 mcg (ITALY)
Active ingredients: Each patch with an area of 20 cm² contains 6.0 mg of norelgestromin and 0.60 mg of ethinyl estradiol; each patch releases 203 mcg of norelgestromin and 33.9 mcg of ethinyl estradiol over a 24-hour period.
Dosage form
Patch - transdermal therapeutic system.
Pharmacotherapeutic group
Hormonal contraceptives for systemic use.
Indications
Contraception in women.
Evra® is indicated for use in women of reproductive age. The safety and efficacy of the Evra® TTS patch have been established only for women aged 18 to 45 years.
The Evra® patch is not indicated for use during pregnancy and breastfeeding.
The package contains 3 patches.
Patch - transdermal therapeutic system.
Pharmacotherapeutic group
Hormonal contraceptives for systemic use.
Indications
Contraception in women.
Evra® is indicated for use in women of reproductive age. The safety and efficacy of the Evra® TTS patch have been established only for women aged 18 to 45 years.
The Evra® patch is not indicated for use during pregnancy and breastfeeding.
The package contains 3 patches.
